Cladribine Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg

Reference Brands: Mavenclad(US & EU)

Category: Multiple sclerosis

Cladribine tablets inhibit DNA synthesis by targeting lymphocytes, reducing inflammation and immune attack in multiple sclerosis. It decreases relapse rates, slows disease progression, and reduces lesion activity. Benefits include oral convenience, long-lasting effects, fewer doses needed, and improved quality of life for relapsing MS patients. Cladribine tablets is available in Tablet and strengths such as 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cladribine tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Cladribine tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Cladribine tablets, marketed as Mavenclad, are approved in the US by the FDA and in the EU via EMA for relapsing multiple sclerosis (MS). Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and manufacturing data, while the EMA ensures compliance with regional safety, efficacy, and quality standards.